A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-negative B lineage Acute Lymphoblastic Leukemia in Adults
NOT ENROLLING
Trial ID:
NCT02003222 Protocol # :
15-709
Phase
III
Disease Sites
Lymphoid Leukemia
Principal Investigator
DeAngelo, Daniel, J
Site Investigator
Ballen, Karen
Hock, Hanno, R.
McMasters, Malgorzata
Mendez, Lourdes
Site Research Nurses
Durgin, Cassandra
Ramos, Aura
Sato-DiLorenzo, Aya
Toomey-Mathews, Ellen
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #15-709
15-709